secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2026-01-27T23:59:59+00:00
Accession:  0001193125-26-023323
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q4 EPS $8.14 (up 44.6%), revenue $19.5B, $10B buyback authorized
-------------------------------------------------------------------------------

- Q4 revenue $19.513B (+6.7% YoY); net income $1.878B (+30.6%); adjusted EBITDA $4.114B (+10.8%).
- Diluted EPS $8.14 (+44.6%), adjusted EPS $8.01 (+28.8%); same-facility admissions +2.4%, equivalent admissions +2.5%.
- Board authorized new $10B share repurchase program; $750M remained under prior authorization as of Dec 31.
- Quarterly dividend raised to $0.78/share, payable March 31, 2026 to holders of record March 17.
- 2026 guidance: revenue $76.5B-$80B, EPS $29.10-$31.50, adjusted EBITDA $15.55B-$16.45B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312526023323/0001193125-26-023323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312526023323/hca-20260127.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-023323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer